Acute Leukemia: Clinical Cases and Correlates Flashcards

1
Q

What is AML?

A
  • Uncontrolled clonal proliferation and accumulation of neoplastic hematopoietic precursor cells of myeloid lineage
  • –Inhibition of normal hematopoiesis
  • –Defective maturation
  • –Dissemination into blood and other tissues
  • –20% myeloblasts in BM (WHO) or 30% myeloblasts in BM (FAB)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the #1 thing to think about with leukemia? (EXAM)

A

What are the cytogenetics? This drives prognosis and treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are you thinking if you see a patient with fever, chills and swollen glands under neck?

A

Viral illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are you thinking if you see fever, chills, and diffuse adenopathy (all over body)?

A

HIV, AML (leukemia) (BAD STUFF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Who is at increased risk for acute myelogenous leukemia? (EXAM)

A

-Down Syndrome, Ataxia telangiectasia, Fanconi anemia, Li Fraumeni syndrome, Wiskott-Aldrich, familial leukemia, myelodysplasia, PNH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What can cause secondary AML (acute myelogenous leukemia)?

A

Prior chemotherapy, radiation exposure, benzene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the median age of diagnosis for AML? How many cases in the US?

A
  • Median age: 63 (80% > 15) - mostly adults
  • 7,400 deaths in US in 2002
  • 10,600 new cases in US in 2002
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What can AML do the the mouth? (EXAM)

A

Can cause gums to hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinical features associated with AML?

A
  • Pancytopenia (red cells, white cells & platelets reduced)
  • –Anemia (often asymtomatic in elderly)
  • –Neutropenia
  • –Thrombocytopenia
  • B symptoms: fever, night sweats, chills, malaise, weight loss
  • Extremedullary disease - outside of the blood & bone marrow!
  • –Monocytic leukemias are most common (infiltration of leukemia in the gums)
  • –Skin, CNS, orbits, bone, lung, kidney, spleen, liver, ovary
  • Hyperleukocytosis
  • –>100,000 blast count/ml
  • –APML, moncytic AML, inv(16), 11q23
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How should you treat AML?

A

Promptly with hydroxyurea, leukopheresis, chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the two methods of classification of AML?

A

FAB

WHO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does AML look like on a blood film?

A
  • Monocytic blast
  • Cleft in the nucleus of monocytes
  • You’ll also see an auer rod
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the FAB classification?

A
  • > 30% BM myeloblasts
  • M0 (undifferentiated myeloid leukemia)
  • M1 (acute myeloid leukemia without maturation)
  • M2 (acute myeloid leukemia with maturation)
  • M3 (acute promyelocytic leukemia)
  • M4 (acute myelomonocytic leukemia)
  • M5 (acute monocytic leukemia)
  • M6 (acute erythroleukemia)
  • M7 (acute megakaryocytic leukemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the WHO classification of AML?

A
  • > 20% BM myeloblasts
  • AML with recurrent cytogenetic abnormalities
  • –ex: t(8;21), t(15;17), t(inv16), 11q23
  • AML with multilineage dysplasia
  • AML and MDS, therapy-related
  • AML not otherwise categorized
  • –similar to FAB list
  • Acute biphenotypic leukemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the MAJOR PROGNOSTIC FACTOR for AML?

A

CYTOGENETICS - major and most important thing in terms of prognosis and treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are favorable features of the AML? (good prognostic indicators)

A

-Age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are unfavorable features of AML? (poor prognostic indicators)

A
  • Poor risk cytogenetics
  • Age >60
  • Presence of infection or sepsis
  • Poor performance status
  • Presence of prior MDS
  • Secondary AML
  • Extreme leukocytosis
  • Extramedullary disease (enlarged lymph nodes all over - adenopathy all over)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

WHAT IS THE SINGLE MOST IMPORTANT PROGNOSTIC FACTOR FOR AML?

A

CYTOGENETICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What cytogenetic outcomes have a favorable risk?

A

t(8;21) (best), t(16;16), t(15;17)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What cytogenetic outcomes have an intermediate risk?

A

(Normal karyotype)

-NPM1+/Flt3- genotype most favorable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What cytogenetic outcomes have an unfavorable risk?

A

del 5, del 7, trisomy 8, 11q23, other complex karyotypes

22
Q

How do you do cytogenetics?

A
  • Undergo tissue assay
  • Prepare 20 cells in metaphase
  • Pathologist looks at cells under microscope and tells you what’s going on
23
Q

How are most AML cases treated if 60 years or younger?

A
  • Induction chemotherapy with anthracycline (daunorubicin, mitoxantrone, idarubicin) plus cytosine arabinoside. “7 + 3” regimen.
  • If remission obtained (60-70% remission rate), then consolidation chemotherapy or transplantation
  • If no remission, then especially poor prognostic sign
  • –If remission induced with alternative regimen, then consider allergenic transplantation
24
Q

What is the “7 + 3” regimen?

A
  • 7 days of cytosine arabinoside (continuous infusion)
  • 3 days of 3 (idarubicin, mitoxantrone, daunorubicin)
  • They’re in the hospital for 3 weeks
25
Who should receive consolidation chemotherapy and what is it?
- High-dose cytosine arabinoside x 4 cycles - Good risk cytogenetics (8;21, inv16, 15;17) - Normal karyotype with NPM1+, Flt3- - Intermediate risk cytogenetics w/o matched sibling donor or unwilling/unable to have transplant in 1st CR
26
What determines your eligibility for a stem cell transplant?
Poor risk cytogenetics
27
Why is cord blood so good?
- It is so simple and easy to do | - But it's not good because you have such a limited supply (baby is not identified)
28
When should you do allogenic stem cell transplantation?
- Poor risk cytogenetics - Intermediate-risk cytogenetics with matched sibling donor - Extramedullary disease (chloroma) - 1st or 2nd relapse - Donor sources include siblings, children, parents, MUD-matched unknown donor, umbilical cord blood
29
What is autologous stem cell transplantation used for?
- No proven benefit over consolidation chemotherapy in 1st CR - Consider for patients w/o an allogenic donor
30
What type of transplant is better?
Allogenic
31
How are AML cases treated if older than 60 years?
- USUALLY DON'T DO ALLOGENIC TRANSPLANTS - Induction chemotherapy with anthracycline (daunorubicin, mitoxantrone, idarubicin) plus cytosine arabinoside. "7+3" regimen. - If remission obtained (60% remission rate), then consolidation chemotherapy with reduced intensity cytosine arabinoside - Mylotarg (anti-CD33 moAb) coupled to calicheamicin) for relapsed disease - Consider observation and supportive care in lieu of induction chemotherapy
32
Is GVHD (graft vs. host disease) curable?
NO!
33
What are you thinking if patient has fatigue, malaise, fevers?
-Infection, Lyme's, Tick-borne illness
34
What are you thinking if patient has fatigue, malaise, fevers and nosebleed (epistaxis)?
- Thrombocytopenia, problem with coagulation system (less common) - Tick borne illness can also present with thrombocytopenia
35
What is normal range for WBC count?
In single digits
36
What are normal platelets?
150-200 K
37
If fibrinogen is under 100?
Patient is consuming their factors or they don't have good liver function
38
What is a common drug that can elevate WBCs?
Steroids - cause demargination of neutrophils from the vascular system!
39
What can cause fever, fatigue, malaise and nosebleed? What does it look like on a blood smear?
M3 AML - acute promyelocytic leukemia - You'll see heavily granulated promyelocytes! - Stack of AUER RODS seen in cells - Much mononuclear infiltrate is evident in slides!
40
What should you remember about acute promyelocytic leukemia (M3)? (EXAM)
- t(15;17) translocation | - If they relapse, they get arsenic trioxide
41
What should you know about acute promyelocytic leukemia (M3)?
- Most with t(15;17). Creates fusion gene, PML/RAR-alpha - Poor risk disease with t(11;17) - Induction therapy with ATRA plus anthracycline-based chemotherapy - Consolidation with 2 courses anthracycline-based chemotherapy - 2 years maintenance chemotherapy with ATRA, 6-MP, and methotrexate - Relapse - --Arsenic trioxide
42
What commonly happens with APML - M3?
- Auer rods - DIC a common presentation - --Coagulopathy - --Depressed fibrinogen - --Thrombocytopenia - --Fatal hemorrhage
43
If a patient has M3 and DIC. . .
. . .start ATRA (all-trans retinoic acid) in
44
What can you not 'let the sun set on' or miss?
AML M3
45
What do you think when you hear 50 f, fatigue, headache, blurred vision?
- Electrolyte balance - Dehydration - Needs glasses
46
What does 1 gram of hemoglobin equal?
1 unit of blood
47
What is seen in the blood smear of someone with M4 AML?
Hyperleukocytosis - Too big monocytes with cleft in nucleus - Lymphocytes are too large (much larger than red cells) - --Indicates = bone marrow failure
48
What causes fatigue, headache and blurred vision in a patient with M4 AML?
Hyperleukocytosis --Hyperviscosity --Sludging in vasculature with ischemia and/or infarct Leukopheresis to reduce WBC
49
What happens with automated blood counters?
- Can misdiagnose monocytosis - could actually be leukemia | - Cell counters can confuse blasts and monocytes
50
What can happen with a blood transfusion?
- Patient can have new blood type, the HLA of the donor | - This is called 100% donor chimerism - their cells even use the DNA of the donor
51
What are two new treatment paradigms in AML?
1. Flt-3 receptor tyrosine kinase inhibitors - Quizartinib - Effective (47% response rate ) in relapsed AML - May be effective "bridge to transplant" strategy - Studies underway to combine with conventional induction therapy - Notable side-effects include QTc prolongation 2. CBF (core binding factor) - Dasatinib - C-kit overexertion in CBF+ AML